Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 09:54 am Sale |
2024-12-31 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 10,747,760 4.810% |
-2,435,792 (-18.48%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 46,028,125 20.600% |
1,883,181 (+4.27%) |
Filing History |
| 2024-11-14 06:00 am Unchanged |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
CANADA PENSION PLAN INVESTMENT BOARD | 10,175,000 4.600% |
0 (Unchanged) |
Filing History |
| 2024-11-12 4:52 pm Unchanged |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 13,183,552 5.920% |
0 (Unchanged) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 31,609,175 14.208% |
9,441,625 (+42.59%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
BLACKROCK INC BLK |
11,817,380 5.300% |
0 (Unchanged) |
Filing History |
| 2024-11-04 2:10 pm Purchase |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 13,183,552 5.920% |
13,183,552 (New Position) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
BLACKROCK INC BLK |
11,817,380 5.300% |
11,817,380 (New Position) |
Filing History |
| 2024-04-03 09:52 am Purchase |
2024-04-02 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 22,167,550 10.055% |
6,416,259 (+40.73%) |
Filing History |
| 2024-03-07 07:01 am Purchase |
2024-02-29 | 13G | Sana Biotechnology, Inc. SANA |
BAILLIE GIFFORD & CO | 10,360,620 4.700% |
210,603 (+2.07%) |
Filing History |
| 2024-02-14 4:19 pm Sale |
2023-12-31 | 13G | Sana Biotechnology, Inc. SANA |
Flagship Ventures Fund V, L.P. | 25,583,551 13.000% |
-8,655,467 (-25.28%) |
Filing History |
| 2024-02-09 5:35 pm Purchase |
2023-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,144,944 22.400% |
65,536 (+0.15%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 15,751,291 7.990% |
6,046,193 (+62.30%) |
Filing History |
| 2024-01-26 06:49 am Sale |
2023-12-29 | 13G | Sana Biotechnology, Inc. SANA |
BAILLIE GIFFORD & CO | 10,150,017 5.150% |
-614,710 (-5.71%) |
Filing History |
| 2023-04-26 08:13 am Purchase |
2023-04-26 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,705,098 5.071% |
535,688 (+5.84%) |
Filing History |
| 2023-02-13 4:07 pm Purchase |
2022-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,079,408 23.100% |
817 (+0.00%) |
Filing History |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,169,410 4.807% |
-323,585 (-3.41%) |
Filing History |
| 2023-01-20 07:41 am Sale |
2022-12-30 | 13G | Sana Biotechnology, Inc. SANA |
BAILLIE GIFFORD & CO | 10,764,727 5.640% |
-497,303 (-4.42%) |
Filing History |
| 2022-05-19 08:27 am Purchase |
2022-05-18 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,492,995 5.005% |
865,144 (+10.03%) |
Filing History |
| 2022-02-14 4:48 pm Purchase |
2021-12-31 | 13G | Sana Biotechnology, Inc. SANA |
CANADA PENSION PLAN INVESTMENT BOARD | 10,175,000 5.400% |
10,175,000 (New Position) |
Filing History |